Results 171 to 180 of about 23,499 (227)

Telitacicept versus belimumab in proliferative lupus nephritis. [PDF]

Front Immunol
Wang C, Zhang MZ, Yun XY, Li LX, Shan JW, Liu B, Li B.   +6 more
europepmc   +1 more source

Endothelial mechanosensitive transcription factor BHLHE40 induced by Piezo1 suppresses endothelial ferroptosis and inflammation via SLC7A11. [PDF]

Cell Death Discov
Miao S, Dai X, Li X, Chen Z, Wang Y, Ye T, Ying Y, Yu Y, Wu A, Song H, Teng P, Ma L, Zheng Q.   +12 more
europepmc   +1 more source

The cyclase-associated protein contributes to antifungal susceptibility and virulence in <i>Aspergillus fumigatus</i>. [PDF]

Emerg Microbes Infect
Yang X, Wang Q, Xiao B, Wang Q, Deng W, Osherov N, Li R, Liu W.   +7 more
europepmc   +1 more source

Machine learning-based predictive model for the perioperative co-occurrence of T-cell-mediated rejection and pneumonia in liver transplantation. [PDF]

Front Immunol
Sun J, Zhu G, Liang Q, Wen N, Li H, Sun X.   +5 more
europepmc   +1 more source

Evaluation of cyclophosphamide for steroid-refractory hepatic acute graft-vs-host disease after allogeneic hematopoietic stem cell transplantation. [PDF]

Front Immunol
Lu N, Zheng Y, Guo W, Zheng X, Feng D, Cao Y, Zhang R, Zhai W, Yang D, Wei J, He Y, Pang A, Feng S, Han M, Jiang E.   +14 more
europepmc   +1 more source

Topical Application of FK506

Topical Application of FK506
openaire  

Some of the next articles are maybe not open access.

Related searches:

Immunophilin FK506-Binding Protein 52 (Not FK506-Binding Protein 12) Mediates the Neurotrophic Action of FK506

Journal of Pharmacology and Experimental Therapeutics, 1999
The neurotrophic property of the immunosuppressant drug FK506 (tacrolimus) is believed to depend on the 12-kDa FK506-binding protein (FKBP-12). Here, we show that FK506 maintains its neurotrophic activity in primary hippocampal cell cultures from FKBP-12 knockout mice.
Bruce G Gold, Weinian Shou, Martin M Matzuk   +2 more
exaly   +3 more sources

Crystal Structure of the FK506 Binding Domain of Plasmodium falciparum FKBP35 in Complex with FK506

Biochemistry, 2008
The emergence of multi-drug-resistant strains of Plasmodium parasites has prompted the search for alternative therapeutic strategies for combating malaria. One possible strategy is to exploit existing drugs as lead compounds. FK506 is currently used in the clinic for preventing transplant rejection.
Ye, H, Alag, R, Hu, G, Preiser, PR, Bozdech, Z, Ho, SY, Lescar, J, Kotaka, M   +7 more
openaire   +6 more sources